• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ardelyx, Inc. - Common Stock (NQ:ARDX)

3.765 -0.055 (-1.44%)
Streaming Delayed Price Updated: 11:23 AM EDT, Aug 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 799,512
Open 3.810
Bid (Size) 3.760 (18,300)
Ask (Size) 3.770 (18,600)
Prev. Close 3.820
Today's Range 3.760 - 3.830
52wk Range 3.725 - 8.400
Shares Outstanding 103,119,010
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
ARDX Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Ardelyx (ARDX)
August 17, 2026
From Levi & Korsinsky, LLP
Via Business Wire
News headline image
Ardelyx (ARDX) Q2 2026 Earnings Call Transcript ↗
August 13, 2026
Record revenue masks payer headwinds forcing IBSRELA guidance cuts. 
Via The Motley Fool
Topics Earnings Economy

Performance

YTD
-38.8%
-38.8%
1 Month
-26.0%
-26.0%
3 Month
-39.8%
-39.8%
6 Month
-43.2%
-43.2%
1 Year
-39.2%
-39.2%

More News

Read More
Ardelyx (NASDAQ:ARDX) Plunges After Q2 Miss and Guidance Cut ↗
August 06, 2026
Via Chartmill
News headline image
Ardelyx Q2 Earnings Call Highlights ↗
August 06, 2026
Via MarketBeat
Topics Earnings
Ardelyx Inc (NASDAQ:ARDX) Reports Strong Q1 Revenue Beat as IBSRELA Momentum Accelerates ↗
April 30, 2026
Via Chartmill
News headline image
Ardelyx Reports Second Quarter 2026 Financial Results and Provides Business Update
August 06, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026
July 23, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Stock Up 70%: What to Know About This $490,000 Insider Transaction ↗
June 23, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Ardelyx Eyes $500M+ Revenue as IBSRELA Growth Puts Profitability Within Reach ↗
June 04, 2026
Via MarketBeat
News headline image
Ardelyx to Participate at the Jefferies Global Healthcare Conference 2026
May 19, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings
May 07, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx (ARDX) Q1 2026 Earnings Transcript ↗
April 30, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update
April 30, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings
April 27, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026
April 23, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
April 20, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026
April 16, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx President and CEO Sells 41,000 Shares for $243,000 ↗
April 03, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx
April 01, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Announces Recipients of the 2026 Derek Forfang Patient Advocate Award
March 12, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx Announces Publication of a Review Article Demonstrating Rapid and Meaningful Symptom Relief with Tenapanor in IBS-C
March 09, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx to Participate in Upcoming Investor Conferences
March 04, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx CEO Sells 41k Shares as Company Announces Huge Partnership ↗
March 01, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Ardelyx and the LPGA Announce Multi-Year Partnership to Break Stigma Around Digestive Health Issues Impacting Millions
February 24, 2026
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
ARDX Stock Jumps Over 5% Overnight As Director Loads Up In Vote Of Confidence For Flagship Constipation Drug ↗
February 24, 2026
Via Stocktwits

Frequently Asked Questions

Is Ardelyx, Inc. - Common Stock publicly traded?
Yes, Ardelyx, Inc. - Common Stock is publicly traded.
What exchange does Ardelyx, Inc. - Common Stock trade on?
Ardelyx, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ardelyx, Inc. - Common Stock?
The ticker symbol for Ardelyx, Inc. - Common Stock is ARDX on the Nasdaq Stock Market
What is the current price of Ardelyx, Inc. - Common Stock?
The current price of Ardelyx, Inc. - Common Stock is 3.765
When was Ardelyx, Inc. - Common Stock last traded?
The last trade of Ardelyx, Inc. - Common Stock was at 08/28/26 11:23 AM ET
What is the market capitalization of Ardelyx, Inc. - Common Stock?
The market capitalization of Ardelyx, Inc. - Common Stock is 388.24M
How many shares of Ardelyx, Inc. - Common Stock are outstanding?
Ardelyx, Inc. - Common Stock has 388M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap